cGxP.wire https://validator.w3.org/feed/docs/rss2.html Neuraly Inc Advances NLY01 Phase 2 MS Trial AbbVie Showcases IBD Data for Skyrizi and Rinvoq Verana Health Enhances Clinical Trial Enrollment Tech Viridian Therapeutics Reports Positive REVEAL-2 Results Johnson & Johnson Reports OTTAVA Surgical Robot Data Amylyx Pharmaceuticals Launches Avexitide Access Program Alpha Tau Medical Ltd. Showcases Alpha DaRT Data Mirum Volixibat Achieves Phase 2b Success in PSC Trial Ortho Development Launches Trivicta Hip Stem in US Takeda Canada Secures REVESTIVE Reimbursement in BC Lilly Omvoh Shows 4-Year UC Disease Clearance Results ImmunityBio to Present ANKTIVA Data at AUA 2026 Sensei Doses First Patient in PIKTOR Breast Trial Insulet Launches EVOLVE Study for Closed Loop System Lannett Secures FDA Nod for Interchangeable Insulin Nanobiotix Updates Phase 3 NANORAY-312 Protocol Opus Genetics Enters FDA RDEP Program for OPGx-LCA5 Cellenkos Secures FDA IND Clearance for CK0802 in GVHD Trial Johnson & Johnson Highlights CAPLYTA Superiority in MDD Study Telix Pharmaceuticals Publishes TLX250-Px Kidney Study TriSalus Life Sciences Launches PREDICTT Trial Caris Life Sciences Gains MolDX Approval for ChromoSeq MMI Launches REMIND Trial Using Symani System UCB to Acquire Candid Therapeutics in $2.2B Immunology Deal Castle Biosciences Unveils TissueCypher Data at DDW 2026 ADMA Biologics Gains FDA Nod to Expand ASCENIV Aktis Oncology Starts Phase 1b Trial for AKY-2519 Oncolytics Biotech Reports Strong mCRC Response Data Ascidian Therapeutics Advances ACDN-01 in Stargardt Trial Insmed Unveils Phase 3 ARIKAYCE Data at ATS 2026 GRIN Therapeutics Initiates Phase 3 Beeline Study Atossa Gains FDA RPD Status for Z-Endoxifen in MAS ARCHIMED to Acquire Esperion Therapeutics in $1.1B Deal Celcuity Reports Phase 3 Success for Gedatolisib in Breast Cancer BioCryst, Neopharmed Sign $345M Europe HAE Deal Harvard Study Shows AI Outperforms Doctors in Diagnosis Moleculent Raises $20M to Scale Functional Profiling Platform InspireMD Initiates U.S. Recall of CGuard Prime System Incyte Corporation Wins FDA Approval for Jakafi XR InspireMD, Inc. Secures FDA IDE for CGUARDIANS III Merck Enpatoran Enters Phase 3 Trial for Lupus Treatment Vector Science & Therapeutics Files Patent for Platform Everads Injector Shows Strong Results in Retinal Study Specialised Therapeutics NIKTIMVO Approved for cGVHD Rezolute, Inc. Reports Phase 3 sunRIZE Data in HI BioMarin VOXZOGO Shows Long-Term Growth Benefits SK Capital Partners Sells Noramco Group to Siegfried Scribe Therapeutics Showcases CRISPR and STX-1150 Data Arvinas Inc Gains FDA Approval for VEPPANU PROTAC Drug Rhythm Pharmaceuticals Secures EU Approval for IMCIVREE